IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses

被引:97
作者
McBride, JM [1 ]
Jung, T [1 ]
de Vries, JE [1 ]
Aversa, G [1 ]
机构
[1] Novartis Res Inst, Autoimmune Dis Unit, A-1235 Vienna, Austria
关键词
human; dendritic cells; tolerance/suppression; lipopolysaccharide; cytokines;
D O I
10.1016/S0008-8749(02)00007-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IL-10 is a potent inhibitor of T-cell activation and has tolerizing effects on these cells. These effects are primarily mediated via modulation of antigen presenting cell function. Here, it is demonstrated that IL-10 completely inhibits LPS-induced DC maturation, resulting in altered DC-T-cell interactions and reduced T-cell responses. IL-10 inhibited LPS-induced upregulation of costimulatory molecules, MHC Class II, and the secretion of IL-12, TNF-alpha, IL-6, and IL-1beta by DCs, although it upregulated the SLAM (CD150) expression at both the mRNA and protein levels. IL-10 pre-treated DC did not respond to subsequent LPS activation and its stimulatory ability for allogeneic and antigen-specific T-cells was severely impaired. Importantly, T-cells derived from co-cultures with Ag-pulsed, IL-10-treated DC were impaired in their responses to subsequent Ag-specific restimulation. Transwell and DC-derived plasma membrane experiments indicated that the capacity of IL-10-treated DC to induce T-cell unresponsiveness results from alterations in the cell surface molecules rather than modulation of cytokine secretion. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:162 / 172
页数:11
相关论文
共 37 条
  • [1] Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
  • [2] 2-4
  • [3] [Anonymous], 1991, J EXP MED, DOI DOI 10.1084/JEM.174.4.915
  • [4] SLAM and its role in T cell activation and Th cell responses
    Aversa, G
    Carballido, J
    Punnonen, J
    Chang, CCJ
    Hauser, T
    Cocks, BG
    DeVries, JE
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02) : 202 - 205
  • [5] Aversa G, 1997, J IMMUNOL, V158, P4036
  • [6] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [7] INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE
    BERG, DJ
    KUHN, R
    RAJEWSKY, K
    MULLER, W
    MENON, S
    DAVIDSON, N
    GRUNIG, G
    RENNICK, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2339 - 2347
  • [8] Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines
    Bleharski, JR
    Niazi, KR
    Sieling, PA
    Cheng, GH
    Modlin, RL
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (06) : 3174 - 3181
  • [9] INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS
    BUELENS, C
    WILLEMS, F
    DELVAUX, A
    PIERARD, G
    DELVILLE, JP
    VELU, T
    GOLDMAN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2668 - 2672
  • [10] Origin, maturation and antigen presenting function of dendritic cells
    Cella, M
    Sallusto, F
    Lanzavecchia, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 10 - 16